Skip to main content
OpenTrials
Completed

NCT Number: NCT01081197

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.

The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Disease Alcohol-Induced Disorders Alcohol-Induced Disorders, Nervous System Alcohol-Related Disorders Alcoholic Neuropathy Behavior Behavioral Symptoms Cardiovascular Diseases Chemically-Induced Disorders Depression Depressive Disorder Digestive System Diseases Heart Diseases Heart Failure Hepatic Insufficiency Liver Diseases Liver Failure Mental Disorders Mood Disorders Nervous System Diseases Neuromuscular Diseases Neurotoxicity Syndromes Peripheral Nervous System Diseases Poisoning Polyneuropathies Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Levanger Hospital, Dep. of Psychiatry

Levanger, N-7600, Norway

About this study

Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway

Exclusion criteria

  • Not consenting to participate
  • Not able to consent

Treatment and study plan

Psychiatric and somatic examinations and ,if clinical indicated, treatment

Other

Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.

Primary outcomes

  1. Prevalence of different kinds of somatic disease

    Time frame: 3 months after inclusion

    Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.

Secondary outcomes

  1. Prevalence of former somatic disease

    Time frame: 3 months after inclusion

    Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.

  2. Outcome of psychiatric and somatic treatment of alcohol abusers

    Time frame: 1 year after stopped inclusion

    Quality of life and score of somatic and psychiatric health 1 year after inclusion

Sponsors and collaborators

Lead sponsor

Helse Nord-Trøndelag HF

Other

Registry information

Official study title

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic. A Neglected Area

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Mar 5, 2010
Registry last updated
Nov 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.